Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

Dose-Response Relationship: Overview

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

Dose-Response Relationship: Selectivity and Specificity

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma.

Blood·2021

Same author

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.

Cancer chemotherapy and pharmacology·2020

Same author

Regression multiple imputation for missing data analysis.

Statistical methods in medical research·2020

Same author

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.

Cancer chemotherapy and pharmacology·2020

Same author

A Serious Flaw in Nutrition Epidemiology: A Meta-Analysis Study.

The international journal of biostatistics·2018

Same author

Number Needed to Treat in Multiple Sclerosis Clinical Trials.

Neurology and therapy·2017

Same journal

Correction.

Journal of biopharmaceutical statistics·2026

Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026

Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026

Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026

Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026

Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

Multivariate dose response test.

Kao-Tai Tsai¹, Karl E Peace

¹Global Biometrics Science, Bristol-Myers Squibb Co, Princeton, New Jersey, USA.

Journal of Biopharmaceutical Statistics

|February 13, 2009

Summary

This summary is machine-generated.

This study introduces a new multivariate statistical test for evaluating drug efficacy in neuroscience clinical trials. The method simultaneously assesses multiple efficacy measures for a more comprehensive treatment evaluation.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

Basics of Multivariate Analysis in Neuroimaging Data

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Area of Science:

Neuroscience
Clinical Trials
Biostatistics

Background:

Neuroscience clinical research often involves testing various drug doses to balance efficacy and side effects.
Efficacy is typically measured using multiple, often binary or ordinal, psychometric instruments.
Individual assessment of each instrument limits comprehensive treatment evaluation.

Purpose of the Study:

To develop a statistical method for the simultaneous assessment of treatment efficacy using multiple instruments.
To address the limitations of conventional, per-instrument efficacy evaluation.
To provide an overall assessment of dose-response relationships in clinical trials.

Main Methods:

A multivariate statistical test for dose-response assessment was developed.
The test simultaneously evaluates efficacy across various psychometric instruments.
Asymptotic distribution of the proposed test was derived.

Main Results:

The study derived the asymptotic distribution for the novel multivariate test.
The proposed method allows for a combined assessment of efficacy from multiple measures.
The method was demonstrated using data from a neuroscience clinical trial.

Conclusions:

The developed multivariate method offers a more integrated approach to evaluating treatment efficacy in neuroscience.
This approach enhances the comprehensive assessment of drug effects by combining multiple efficacy indicators.
The findings support the use of multivariate statistical methods for improved clinical trial analysis.